Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Psiquiatría | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
A Non-Interventional Prospective Cohort Study of Patients With Persistent Symptoms of Schizophrenia to Describe The Course and Burden of Illness
OBSERVATIONAL
Inicio: 1 de feb de 2011
ID: NCT01634542
Completado
Fase 4
ClinicalTrials.gov
An Open-label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Subjects With Schizophrenia
INTERVENTIONAL
Inicio: 1 de feb de 2008
ID: NCT01724359
Completado
Fase 3
ClinicalTrials.gov
An Open- Label Rollover Study for Subjects With Schizophrenia Completing ABILIFY® (Aripiprazole) Clinical Study 31-03-241
INTERVENTIONAL
Inicio: 1 de abr de 2006
ID: NCT01001702
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
INTERVENTIONAL
Inicio: 1 de ago de 2005
ID: NCT00273039
Completado
Fase 2
ClinicalTrials.gov
A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety, Tolerability and Efficacy of Multiple Sublingual Microdoses of 5-MeO-DMT in Reducing Symptoms of Depression and/or Anxiety.
INTERVENTIONAL
Inicio: 21 de oct de 2024
ID: NCT06816667
Completado
Fase 3
ClinicalTrials.gov
A Fifty-Two-Week Multicenter, Open-Label, Study Evaluating the Long-Term Safety and Tolerability of SR58611A 350 mg q12 in Patients With Major Depressive Disorder.
INTERVENTIONAL
Inicio: 1 de sept de 2005
ID: NCT00855530
Completado
Fase 3
ClinicalTrials.gov
A Double-Blind, Multi-Center, Multinational, Randomized Withdrawal Study Evaluating the Efficacy and Safety of SR58611A (350mg q12) Versus Placebo in the Prevention of Depression Relapse up to 1 Year in Patients With Major Depressive Disorder Improved After 12 Weeks of Open Treatment With SR58611A (350mg q12)
INTERVENTIONAL
Inicio: 1 de may de 2006
ID: NCT00345098
Completado
Fase 3
ClinicalTrials.gov
A Prospective Randomized Open-label 6-Month Head-To-Head Trial to Compare Metabolic Effects of Paliperidone ER and Olanzapine in Subjects With Schizophrenia
INTERVENTIONAL
Inicio: 1 de oct de 2007
ID: NCT00645099
Completado
ClinicalTrials.gov
Evolution of Quality of Life, Functional Capacity, Nutritional Status and Return to Work Activity in Patients Admitted for Severe Pneumonia Due to COVID 19 Requiring Invasive Mechanical Ventilation
OBSERVATIONAL
Inicio: 1 de jun de 2020
ID: NCT06727474
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment With Brenipatide in Delaying Time to Relapse Compared With Placebo in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
INTERVENTIONAL
Inicio: 24 de nov de 2025
ID: NCT07286175
Completado
Fase 4
ClinicalTrials.gov
Long Term Safety And Efficacy Study Of Pregabalin (Lyrica) In Subjects With Generalized Anxiety Disorder
INTERVENTIONAL
Inicio: 1 de may de 2009
ID: NCT00624780
Completado
Fase 2
ClinicalTrials.gov
A Multi-Center, Inpatient, Phase 2, Double-blind, Placebo-Controlled Dose Ranging Study of LY2140023 in Patients With DSM-IV Schizophrenia
INTERVENTIONAL
Inicio: 1 de sept de 2007
ID: NCT00520923
Terminado
Fase 2
ClinicalTrials.gov
A Multicenter, Double-Blind, 58 Week Rollover Study to Assess the Safety and Tolerability of BMS-820836 in Patients With Treatment Resistant Major Depression
INTERVENTIONAL
Inicio: 1 de ago de 2011
ID: NCT01361555
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Multicenter, Double-Blind, Parallel Group Study To Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients
INTERVENTIONAL
Inicio: 1 de abr de 2007
ID: NCT00396214
Completado
Fase 3
ClinicalTrials.gov
Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder
INTERVENTIONAL
Inicio: 1 de jun de 2002
ID: NCT00046384
Desconocido
ClinicalTrials.gov
The Impact of the Covid-19 Pandemic on the Mental Health of Workers in Health Services: The Covid-19 HEalth caRe wOrkErS (HEROES) Study
OBSERVATIONAL
Inicio: 26 de abr de 2020
ID: NCT04352634
Completado
Fase 3
ClinicalTrials.gov
Long-Term Safety, Tolerability, and Effectiveness of Lurasidone in Subjects With Schizophrenia or Schizoaffective Disorder: A Randomized, Active Comparator-Controlled Trial
INTERVENTIONAL
Inicio: 1 de mar de 2008
ID: NCT00641745
Completado
Fase 3
ClinicalTrials.gov
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
INTERVENTIONAL
Inicio: 1 de jul de 2008
ID: NCT00705783
Completado
Fase 3
ClinicalTrials.gov
A Comparison of Duloxetine Hydrochloride, Venlafaxine Extended Release, and Placebo in the Treatment of Generalized Anxiety Disorder
INTERVENTIONAL
Inicio: 1 de abr de 2005
ID: NCT00122837
Reclutando
ClinicalTrials.gov
Trauma-informed Obstetric Care for Perinatal Health in Women With Histories of Childhood Abuse: a Pilot Randomized Clinical Trial
INTERVENTIONAL
Inicio: 23 de may de 2025
ID: NCT07195058
Anterior
1
2
3
...
434
Siguiente
Filtros